Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
about
sameAs
Von Willebrand factor in patients on mechanical circulatory support - a double-edged sword between bleeding and thrombosisEvaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic SubstrateBiomarkers for strokeEffects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillationEHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and micePersonalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.von Willebrand factor: two sides of a coin.The role of von Willebrand factor in hemorrhagic and thrombotic disorders.Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults.Stroke: morbidity, risk factors, and care in taiwanVon Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.von Willebrand factor: an emerging target in stroke therapy.Virchow's triad revisited: blood constituents.Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillationGastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.Prothrombotic risk factors and antithrombotic therapy in children with ischemic strokeRapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitorAntithrombotic treatment in atrial fibrillation.Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillationAntithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients.Assessment of endothelial dysfunction: focus on atherothrombotic disease.Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice.How a damaged blood vessel wall contibutes to thrombosis and hypertenasion.Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillationThrombotic complications in von Willebrand disease.Stroke in Atrial Fibrillation - Long-term Follow-up of Cardiovascular Events.von Willebrand factor, endothelial dysfunction, and cardiovascular disease.Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial.Safety of human plasma-derived clotting factor products and their role in haemostasis in patients with haemophilia: meeting report.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Pharmacotherapy of atrial fibrillation: an old option with new possibilities.Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report.Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.
P2860
Q26772079-7A932831-07E7-43C3-A532-61D33E1F6D51Q26799163-F4757397-739F-4E7A-8724-C68A0ADD5F0FQ27004404-3D93A8A9-686F-4F82-8759-48B3B1FDF726Q28175492-E6FD160F-B961-4805-9876-DEDB7F1EBA90Q30375302-7EE80D3E-A3A2-445B-9671-0AEA361BA655Q30497987-60F76677-C263-4122-B81F-AA15262DB021Q30663685-F306CFFC-3CA0-44AF-9D01-B01608C12728Q33367858-57B1DB7A-A83B-4A78-9F36-B6A76C2F2FF1Q33374578-BBFF6AF7-B491-4D54-B49B-7733D746D407Q33577406-9FAE7B80-C3D3-4CBB-BB24-214C2F094FA2Q33725910-3ED764D8-087D-4531-A889-793E6177864DQ33765871-359515E9-548E-4995-BBB0-A5154275CB65Q33768997-B9AE1EE3-EC43-48DA-8936-21FC6A90AB60Q33872912-0E4EA3C5-EC73-469C-97EB-74F524AC060EQ33915674-49686B62-3E61-476E-9556-CB2CD6FF256CQ34391060-C9826878-9DE9-42DA-9145-7382AA66559AQ34512403-47D38C58-AA74-4CFE-A736-3A7C944A5CB5Q34749456-A4E2935E-F3A4-4D86-821C-9A51AB17E48BQ35071894-487DE1EE-EFD6-4FE7-9997-80F2FE7515A9Q35121586-878626B5-5DD1-48EC-B11B-42D71233CCB3Q35168617-4545266B-130E-4815-B390-E1F250E99143Q35750010-D1F86520-2DA5-4A0A-B3E4-13B8230FD2CEQ35771277-BEEE442C-EE53-43C4-811B-87AA69DDFEA5Q35773343-C7A2406C-4280-4306-8E65-3A39233B6293Q35777336-2E8762D0-0282-48F6-BA21-047F9A8C5A40Q35827375-3B8EFAE3-01B8-42A4-8D76-75FDFE038EA6Q36030409-0FE252D6-8554-4756-935E-FA5AA1A68826Q36030428-550433B6-661E-450F-8BFF-9840342EBBD6Q36030541-15F9DE83-7510-4F9A-819C-C0F2FE69A51BQ36087921-5280AD3D-1FB1-4624-AF64-8540584C472AQ36415995-584194BE-5A43-448D-89E8-C04596B5ABEAQ36458873-1C48C09C-CA30-4AD8-AAF2-ADB6B598E4DFQ36481209-9A46AB07-A2ED-49A6-97B9-F38CA8543DCFQ36501853-9543C5B2-A0A0-4E2E-BE6A-5ED12CE5AAB1Q36806310-6FCFC183-3084-4988-894B-708E67D3BDCFQ36945970-42E3ABB1-70AF-4851-BEF6-9E56FFAB6C0AQ37100261-23ABFCEB-2605-4317-98E4-9F2C5B278A7AQ37123391-C57D016D-2468-4A7E-BAE5-573A7B92E1ECQ37406523-FA38E830-2035-4047-85DC-2814B6BB1787Q37464600-C96DB6F5-EA5B-438A-9245-C8D2E72D0E22
P2860
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@ast
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@en
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@nl
type
label
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@ast
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@en
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@nl
prefLabel
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@ast
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@en
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@nl
P2093
P921
P3181
P1433
P1476
Prognostic value of plasma von ...... onvalvular atrial fibrillation
@en
P2093
Bernard S P Chin
Dwayne S G Conway
Lesly A Pearce
Robert G Hart
P304
P3181
P356
10.1161/01.CIR.0000077912.12202.FC
P407
P577
2003-07-01T00:00:00Z